Kobliska David R MD is categorized under Blood Related Health Services in Pleasantville, IA .
Kobliska David R MD was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David Kobliska at the company’s single location by writing to 104 North Washington St, Pleasantville, Iowa IA 50225 or by phoning (515) 848-3113. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kobliska David R MD |
| Contact Person: | David Kobliska |
| Address: | 104 North Washington St, Pleasantville, Iowa 50225 |
| Phone Number: | (515) 848-3113 |
| Website Address: | knoxvillehospital.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Kobliska David R MD was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Kobliska for inquiries that concern Kobliska David R MD by calling the company number (515) 848-3113, as your correspondence is most welcome. Additionally, the physical location of the single location of Kobliska David R MD can be found at the coordinates 41.38673,-93.2693 as well as the street address 104 North Washington St in Pleasantville, Iowa 50225.
For its online presence, you may visit Kobliska David R MD’s website at knoxvillehospital.org and engage with its social media outlets through on Twitter and on Facebook.